Cell And Gene Therapy CDMO Market (2025 - 2033) Size, Share & Trends Analysis Report By Phase (Pre-clinical, Clinical), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases), By Region, And Segment Forecasts

Market Segmentation

• Cell and Gene Therapy CDMO Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-clinical
  • Clinical
• Cell and Gene Therapy CDMO Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Gene Therapy
    • Ex-vivo
    • In-vivo
  • Gene-Modified Cell Therapy
    • CAR T-cell therapies
    • CAR-NK cell therapy
    • TCR-T cell therapy
    • Other
  • Cell Therapy
• Cell and Gene Therapy CDMO Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Neurological disorders
  • Rare Diseases
  • Others
• Cell and Gene Therapy CDMO Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • North America Cell And Gene Therapy CDMO Market, By phase
      • Pre-clinical
      • Clinical
    • North America Cell And Gene Therapy CDMO Market, by product
      • Gene Therapy
        • Ex-vivo
        • In-vivo
      • Gene-Modified Cell Therapy
        • CAR T-cell therapies
        • CAR-NK cell therapy
        • TCR-T cell therapy
        • Other
      • Cell Therapy
    • North America Cell And Gene Therapy CDMO Market, By Indication
      • Oncology
      • Infectious Diseases
      • Neurological disorders
      • Rare Diseases
      • Others
    • U.S.
      • U.S. Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • U.S. Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • U.S. Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Canada
      • Canada Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Canada Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Canada Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Mexico
      • Mexico Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Mexico Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Mexico Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
  • Europe
    • Europe Cell And Gene Therapy CDMO Market, By phase
      • Pre-clinical
      • Clinical
    • Europe Cell And Gene Therapy CDMO Market, by product
      • Gene Therapy
        • Ex-vivo
        • In-vivo
      • Gene-Modified Cell Therapy
        • CAR T-cell therapies
        • CAR-NK cell therapy
        • TCR-T cell therapy
        • Other
      • Cell Therapy
    • Europe Cell And Gene Therapy CDMO Market, By Indication
      • Oncology
      • Infectious Diseases
      • Neurological disorders
      • Rare Diseases
      • Others
    • UK
      • UK Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • UK Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • UK Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Germany
      • Germany Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Germany Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Germany Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • France
      • France Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • France Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • France Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Italy
      • Italy Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Italy Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Italy Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Spain
      • Spain Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Spain Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Spain Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Denmark
      • Denmark Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Denmark Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Denmark Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Norway
      • Norway Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Norway Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Norway Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Sweden
      • Sweden Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Sweden Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Sweden Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
  • Asia Pacific
    • Asia Pacific Cell And Gene Therapy CDMO Market, By phase
      • Pre-clinical
      • Clinical
    • Asia Pacific Cell And Gene Therapy CDMO Market, by product
      • Gene Therapy
        • Ex-vivo
        • In-vivo
      • Gene-Modified Cell Therapy
        • CAR T-cell therapies
        • CAR-NK cell therapy
        • TCR-T cell therapy
        • Other
      • Cell Therapy
    • Asia Pacific Cell And Gene Therapy CDMO Market, By Indication
      • Oncology
      • Infectious Diseases
      • Neurological disorders
      • Rare Diseases
      • Others
    • Japan
      • Japan Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Japan Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Japan Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • China
      • China Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • China Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • China Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • India
      • India Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • India Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • India Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Australia
      • Australia Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Australia Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Australia Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • South Korea
      • South Korea Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • South Korea Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • South Korea Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Thailand
      • Thailand Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Thailand Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Thailand Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
  • Latin America
    • Latin America Cell And Gene Therapy CDMO Market, By phase
      • Pre-clinical
      • Clinical
    • Latin America Cell And Gene Therapy CDMO Market, by product
      • Gene Therapy
        • Ex-vivo
        • In-vivo
      • Gene-Modified Cell Therapy
        • CAR T-cell therapies
        • CAR-NK cell therapy
        • TCR-T cell therapy
        • Other
      • Cell Therapy
    • Latin America Cell And Gene Therapy CDMO Market, By Indication
      • Oncology
      • Infectious Diseases
      • Neurological disorders
      • Rare Diseases
      • Others
    • Brazil
      • Brazil Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Brazil Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Brazil Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Argentina
      • Argentina Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Argentina Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Argentina Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
  • Middle East and Africa
    • Middle East and Africa Cell And Gene Therapy CDMO Market, By phase
      • Pre-clinical
      • Clinical
    • Middle East and Africa Cell And Gene Therapy CDMO Market, by product
      • Gene Therapy
        • Ex-vivo
        • In-vivo
      • Gene-Modified Cell Therapy
        • CAR T-cell therapies
        • CAR-NK cell therapy
        • TCR-T cell therapy
        • Other
      • Cell Therapy
    • Middle East and Africa Cell And Gene Therapy CDMO Market, By Indication
      • Oncology
      • Infectious Diseases
      • Neurological disorders
      • Rare Diseases
      • Others
    • South Africa
      • South Africa Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • South Africa Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • South Africa Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Saudi Arabia
      • Saudi Arabia Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Saudi Arabia Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Saudi Arabia Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • UAE
      • UAE Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • UAE Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • UAE Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Kuwait
      • Kuwait Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Kuwait Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Kuwait Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Oman
      • Oman Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Oman Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Oman Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others
    • Qatar
      • Qatar Cell And Gene Therapy CDMO Market, By phase
        • Pre-clinical
        • Clinical
      • Qatar Cell And Gene Therapy CDMO Market, by product
        • Gene Therapy
          • Ex-vivo
          • In-vivo
        • Gene-Modified Cell Therapy
          • CAR T-cell therapies
          • CAR-NK cell therapy
          • TCR-T cell therapy
          • Other
        • Cell Therapy
      • Qatar Cell And Gene Therapy CDMO Market, By Indication
        • Oncology
        • Infectious Diseases
        • Neurological disorders
        • Rare Diseases
        • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2021 to 2033
• Market estimates and forecast for product segments up to 2033
• Regional market size and forecast for product segments up to 2033
• Market estimates and forecast for application segments up to 2033
• Regional market size and forecast for application segments up to 2033
• Company financial performance